View Item 

Show simple item record

Core- binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure
dc.contributor.authorUstun, Celalettin
dc.contributor.authorMorgan, Elizabeth A.
dc.contributor.authorRitz, Ethan M
dc.contributor.authorVestergaard, Hanne
dc.contributor.authorPullarkat, Sheeja
dc.contributor.authorKluin, Philip M.
dc.contributor.authorOhgami, Robert
dc.contributor.authorBaughn, Linda B.
dc.contributor.authorKim, Young
dc.contributor.authorKu, Nam K.
dc.contributor.authorCzuchlewski, David
dc.contributor.authorBoe Møller, Michael
dc.contributor.authorSchiefer, Ana‐iris
dc.contributor.authorMrózek, Krzysztof
dc.contributor.authorHorny, Hans‐peter
dc.contributor.authorGeorge, Tracy I.
dc.contributor.authorKielsgaard Kristensen, Thomas
dc.contributor.authorBeck, Todd
dc.contributor.authorNathan, Sunita
dc.contributor.authorArana Yi, Cecilia
dc.contributor.authorYeung, Cecilia
dc.contributor.authorPullarkat, Vinod
dc.contributor.authorGotlib, Jason
dc.contributor.authorAkin, Cem
dc.contributor.authorKohlschmidt, Jessica
dc.contributor.authorSalhotra, Amandeep
dc.contributor.authorSoma, Lori
dc.contributor.authorChen, Dong
dc.contributor.authorHan, Se Y.
dc.contributor.authorCho, Christina
dc.contributor.authorSperr, Wolfgang
dc.contributor.authorBroesby‐olsen, Sigurd
dc.contributor.authorLinden, Michael A.
dc.contributor.authorDolan, Michelle
dc.contributor.authorHoermann, Gregor
dc.contributor.authorHornick, Jason L
dc.contributor.authorBloomfield, Clara
dc.contributor.authorNakamura, Ryo
dc.contributor.authorJoachim Deeg, H.
dc.contributor.authorLitzow, Mark R.
dc.contributor.authorBorthakur, Gautam
dc.contributor.authorWeisdorf, Daniel
dc.contributor.authorHuls, Gerwin
dc.contributor.authorPerales, Miguel‐angel
dc.contributor.authorValent, Peter
dc.contributor.authorMarcucci, Guido
dc.date.accessioned2021-02-04T21:51:37Z
dc.date.available2022-03-04 16:51:35en
dc.date.available2021-02-04T21:51:37Z
dc.date.issued2021-02
dc.identifier.citationUstun, Celalettin; Morgan, Elizabeth A.; Ritz, Ethan M; Vestergaard, Hanne; Pullarkat, Sheeja; Kluin, Philip M.; Ohgami, Robert; Baughn, Linda B.; Kim, Young; Ku, Nam K.; Czuchlewski, David; Boe Møller, Michael ; Schiefer, Ana‐iris ; Mrózek, Krzysztof ; Horny, Hans‐peter ; George, Tracy I.; Kielsgaard Kristensen, Thomas; Beck, Todd; Nathan, Sunita; Arana Yi, Cecilia; Yeung, Cecilia; Pullarkat, Vinod; Gotlib, Jason; Akin, Cem; Kohlschmidt, Jessica; Salhotra, Amandeep; Soma, Lori; Chen, Dong; Han, Se Y.; Cho, Christina; Sperr, Wolfgang; Broesby‐olsen, Sigurd ; Linden, Michael A.; Dolan, Michelle; Hoermann, Gregor; Hornick, Jason L; Bloomfield, Clara; Nakamura, Ryo; Joachim Deeg, H.; Litzow, Mark R.; Borthakur, Gautam; Weisdorf, Daniel; Huls, Gerwin; Perales, Miguel‐angel ; Valent, Peter; Marcucci, Guido (2021). "Core- binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure." International Journal of Laboratory Hematology (1): e19-e25.
dc.identifier.issn1751-5521
dc.identifier.issn1751-553X
dc.identifier.urihttps://hdl.handle.net/2027.42/166221
dc.publisherWiley Periodicals, Inc.
dc.titleCore- binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166221/1/ijlh13338.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166221/2/ijlh13338_am.pdf
dc.identifier.doi10.1111/ijlh.13338
dc.identifier.doihttps://dx.doi.org/10.7302/144
dc.identifier.sourceInternational Journal of Laboratory Hematology
dc.identifier.citedreferenceKawashima N, Ishikawa S, Atsuta Y, et al. Prospective evaluation of prognostic relevance of KIT mutations in core- binding factor acute myeloid leukemia: results from the JALSG CBF- AML209- KIT Study. Blood. 2018; 132: 438.
dc.identifier.citedreferenceSeymour JF, Juneja SK, Campbell LJ, et al. Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel- containing chemotherapy and review of the role of intensified ara- C therapy. Leukemia. 1999; 13: 1735 - 1740.
dc.identifier.citedreferenceHoyos M, Nomdedeu JF, Esteve J, et al. Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease. Eur J Haematol. 2013; 91: 209 - 218.
dc.identifier.citedreferencePaschka P, Du J, Schlenk RF, et al. Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German- Austrian AML Study Group (AMLSG). Blood. 2013; 121: 170 - 177.
dc.identifier.citedreferenceMartin G, Barragan E, Bolufer P, et al. Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement. Haematologica. 2000; 85: 699 - 703.
dc.identifier.citedreferencede Jonge HJ, Valk PJ, de Bont ES, et al. Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3- ITD. Haematologica. 2011; 96: 1310 - 1317.
dc.identifier.citedreferenceDelaunay J, Vey N, Leblanc T, et al. Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup. Blood. 2003; 102: 462 - 469.
dc.identifier.citedreferenceMarcucci G, Mrozek K, Ruppert AS, et al. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. J Clin Oncol. 2005; 23: 5705 - 5717.
dc.identifier.citedreferenceSchlenk RF, Benner A, Krauter J, et al. Individual patient data- based meta- analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. J Clin Oncol. 2004; 22: 3741 - 3750.
dc.identifier.citedreferenceDuployez N, Marceau- Renaut A, Boissel N, et al. Comprehensive mutational profiling of core binding factor acute myeloid leukemia. Blood. 2016; 127: 2451 - 2459.
dc.identifier.citedreferenceMosna F, Papayannidis C, Martinelli G, et al. Complex karyotype, older age, and reduced first- line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long- term follow- up. Am J Hematol. 2015; 90: 515 - 523.
dc.identifier.citedreferenceUstun C, Marcucci G. Emerging diagnostic and therapeutic approaches in core binding factor acute myeloid leukaemia. Curr Opin Hematol. 2015; 22: 85 - 91.
dc.identifier.citedreferenceUstun C, Morgan E, Moodie EEM, et al. Core- binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I- CBFit). Cancer Med. 2018; 7: 4447 - 4455.
dc.working.doi10.7302/144en
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ijlh13338.pdf
Size:
871.2KB
Format:
PDF
View/Open
Name:
ijlh13338_am.pdf
Size:
445.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.